E-LIB Suche - Ergebnisse für: Wiersum-Osselton, J.C.

1

Direct costs of transfusion reactions - an expert judgement..:

Janssen, M. P. ; van Tilborgh, A. J. W. ; de Vooght, K. M. K...
Vox Sanguinis. 113 (2017) 2 - p. 143-151 , 2017

2

Donors' health state the year after peripheral haematopoiet..:

Bank, I. ; Wiersum-Osselton, J.C. ; Van Walraven, S.M....
Journal of Clinical Apheresis. 31 (2016) 6 - p. 523-528 , 2016

Link: https://doi.org/10.1002/..

3

La traçabilité des produits sanguins labiles dans les hôpit..:

Wiersum-Osselton, J.C. ; Van Tilborgh-De Jong, A.J.W. ; Zijlker-Jansen, P.Y..
Transfusion Clinique et Biologique. 21 (2014) 4-5 - p. 267 , 2014

Link: https://doi.org/10.1016/..

4

Plasmapheresis in healthy donors in the Netherlands: Cohort..:

Wiersum-Osselton, J.C. ; Marijt-van der Kreek, T. ; van Dongen, R.
Transfusion and Apheresis Science. 48 (2013) 2 - p. 163 , 2013

Link: https://doi.org/10.1016/..

5

Variabilité de l'incidence des effets indésirables receveur..:

Wiersum-Osselton, J.C. ; Van Tilborgh-De Jong, A.J.W. ; Zijlker-Jansen, P.Y....
Transfusion Clinique et Biologique. 19 (2012) 4-5 - p. 270-271 , 2012

Link: https://doi.org/10.1016/..

6

Les bases de données internationales en hémovigilance:

Wiersum-Osselton, J.C.
Transfusion Clinique et Biologique. 17 (2010) 5-6 - p. 306-309 , 2010

Link: https://doi.org/10.1016/..

7

Haemovigilance for the optimal use of blood products in the..:

Reesink, H. W. ; Panzer, S. ; Gonzalez, C. A....
Vox Sanguinis. 99 (2010) 3 - p. 278-293 , 2010

Link: https://doi.org/10.1111/..

8

Pain is what hurts: An exploration of perception and manage..:

van Walraven, Suzanna M. ; Witte, Leon C. ; Prinsze, Femmeke..
Transfusion and Apheresis Science. 63 (2024) 3 - p. 103908 , 2024

Link: https://doi.org/10.1016/..

9

Wrong blood in tube - potential for serious outcomes: can i..:

Bolton-Maggs, Paula H. B. ; Wood, Erica M. ; Wiersum-Osselton, Johanna C.
British Journal of Haematology. 168 (2014) 1 - p. 3-13 , 2014

Link: https://doi.org/10.1111/..

10

Donor vigilance: What are we doing about it?:

Wiersum-Osselton, Johanna C. ; Marijt-van der Kreek, Tanneke ; de Kort, Wim L.A.M.
Biologicals. 40 (2012) 3 - p. 176-179 , 2012

Link: https://doi.org/10.1016/..

11

Adverse reactions following transfusion of blood components..:

Politis, C. ; Wiersum-Osselton, J. ; Richardson, C....
Transfusion Clinique et Biologique. 29 (2022) 3 - p. 243-249 , 2022

Link: https://doi.org/10.1016/..

12

Haemovigilance:current practices and future developments:

de Jonge, Layla L ; Wiersum-Osselton, Johanna C ; Bokhorst, Arlinke G..
https://research.rug.nl/en/publications/cff5f362-71db-4779-b896-6739f09e3900. , 2022

Link: https://hdl.handle.net/1..

13

Transition from fresh frozen plasma to solvent/detergent pl..:

Saadah, Nicholas H ; Schipperus, Martin R ; Wiersum-Osselton, Johanna C...
Saadah , N H , Schipperus , M R , Wiersum-Osselton , J C , van Kraaij , M G , Caram-Deelder , C , Beckers , E A M , Leyte , A , Rondeel , J M M , de Vooght , K M K , Weerkamp , F , Zwaginga , J J & van der Bom , J G 2020 , ' Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands : comparing clinical use and transfusion reaction risks ' , Haematologica-the Hematology Journal , vol. 105 , no. 4 , pp. 1158-1165 . https://doi.org/10.3324/haematol.2019.222083. , 2020

Link: https://cris.maastrichtu..

14

Risk factors for complications in donors at first and repea..:

Wiersum-Osselton, Johanna C ; Marijt-van derKreek, Tanneke ; Brand, Anneke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934284. , 2014

Link: http://www.ncbi.nlm.nih...

15

New global reporting system for serious (product) events an..:

Jöris, Monique ; Pustjens, Esther ; Mengling, Thilo...
Cell and Tissue Banking. 22 (2020) 2 - p. 191-197 , 2020

Link: https://doi.org/10.1007/..